MB and B-cell non-Hodgkin lymphoma: We demonstrated an ~80-fold higher in vitro binding of the 89Zr-hCD4-Mb in the hCD4+ HBP-ALL cells than in the hCD4- DHL B-cell-lymphoma cells while in vivo accumulation of s.c. injected cells was only ~4-fold higher.